Meanwhile, we confirmed that the YTHDC2 methylation level was closely related to the prognosis of patients with ACC, CESC, LUSC and UCEC, identifying the potential prognostic value of YTHDC2 methylation in the above cancers. Here, YTHDC2 is linked to adrenal cortex carcinoma.